Results 11 to 20 of about 3,871 (249)

Calciphylaxis: Beyond CKD-MBD

open access: yesNefrología (English Edition), 2017
Introduction: Calcific uraemic arteriolopathy (CUA), also called calciphylaxis, is a rare but potentially fatal vascular disorder that almost exclusively affects patients with chronic renal failure. The objective of this study was to analyse various risk
María Fernández   +6 more
doaj   +3 more sources

The Role of DMP1 in CKD-MBD. [PDF]

open access: yesCurr Osteoporos Rep, 2021
Chronic kidney disease-mineral and bone disorder (CKD-MBD) has become a global health crisis with very limited therapeutic options. Dentin matrix protein 1 (DMP1) is a matrix extracellular protein secreted by osteocytes that has generated recent interest for its possible involvement in CKD-MBD pathogenesis.
Martin A, Kentrup D.
europepmc   +3 more sources

The Role of Vitamin K in CKD-MBD. [PDF]

open access: yesCurr Osteoporos Rep, 2022
We describe the mechanism of action of vitamin K, and its implication in cardiovascular disease, bone fractures, and inflammation to underline its protective role, especially in chronic kidney disease (CKD).Vitamin K acts as a coenzyme of y-glutamyl carboxylase, transforming undercarboxylated in carboxylated vitamin K-dependent proteins.
Fusaro M   +15 more
europepmc   +4 more sources

Inositol 1,4,5-trisphosphate receptor type 2 is associated with the bone–vessel axis in chronic kidney disease–mineral bone disorder

open access: yesRenal Failure, 2023
Objective The pathogenesis of renal osteopathy and cardiovascular disease suggests the disordered bone–vessel axis in chronic kidney disease–mineral bone disorder (CKD–MBD).
Qiong Xiao   +11 more
doaj   +1 more source

Antihypertensive treatment with hydrochlorothiazide-hydralazine combination aggravates medial vascular calcification in CKD rats with mineral bone disorder

open access: yesFrontiers in Cardiovascular Medicine, 2023
BackgroundArterial stiffness and medial vascular calcification, leading to isolated systolic blood pressure (BP), are major cardiovascular risk factors in patients with chronic kidney disease (CKD) and mineral bone disorders (MBD).
Richard Larivière   +9 more
doaj   +1 more source

Myocardial Remodeling in Early Chronic Kidney Disease—Mineral and Bone Disorder Model with Low Bone Turnover

open access: yesKidney and Dialysis, 2023
Chronic kidney disease—mineral and bone disorder (CKD-MBD) plays a significant role in causing cardiovascular morbidity and mortality related to CKD.
Evdokia Bogdanova   +8 more
doaj   +1 more source

Diagnosis and Management of Chronic Kidney Disease-Mineral Bone Disease in Children [PDF]

open access: yesChildhood Kidney Diseases, 2020
Chronic kidney disease–mineral bone disorder (CKD–MBD) is a systemic disorder of mineral and bone metabolism caused by CKD. Patients with early-stage CKD who present with disordered regulation of bone and mineral metabolism may be asymptomatic.
Jin-Soon Suh
doaj   +1 more source

The Role of Bone Biopsy in the Management of CKD-MBD: CKD-Related Osteoporosis or CKD-MBD/Osteoporosis? [PDF]

open access: yesCalcified Tissue International, 2021
info:eu-repo/semantics ...
Ana Carina Ferreira   +3 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy